Will using TiO₂-free coatings make my tablets easier to approve globally?
Yes, especially in the EU, where TiO₂ is under review for pharmaceuticals. Moreover, it demonstrates proactive compliance and reduces the risk of reformulation later.
Yes, especially in the EU, where TiO₂ is under review for pharmaceuticals. Moreover, it demonstrates proactive compliance and reduces the risk of reformulation later.
Yes, they are generally as easy to apply as traditional TiO₂-based coatings
Slightly, yes. Without TiO₂, tablets may appear off-white or somewhat translucent, depending on the coating system used.
TiO₂-free coatings are usually made from alternative white pigments and fillers instead of titanium dioxide. Common substitutes include zinc oxide, zinc sulfide, barium sulfate, calcium carbonate, and synthetic opacifiers.
Minor defects may sometimes be corrected by re-coating, but often, significant defects require discarding the batch to avoid risks.
No. Some drugs are unstable in the intestine, poorly soluble, or require immediate release. Enteric coating works only for drugs that benefit from delayed release.
Enteric coating protects the drug from stomach acid and ensures it dissolves in the intestine, where it can be absorbed effectively.
Disintegration tests, dissolution testing in simulated gastric and intestinal fluids, and stability studies are crucial to confirm performance.
Yes. Some coating are designed to delay or prolong drug release. For example, film coating for immediate release.
Tablet coating is typically done in coating pans where coating solutions are sprayed onto rotating or fluidised tablets, followed by drying.